Sarepta Therapeutics (SRPT) PT Lowered to $181 at Baird on CRL for Golodirsen
Tweet Send to a Friend
Baird analyst Brian Skorney lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $181.00 (from $202.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
